* Nephros Inc NEPH.OQ reported a quarterly adjusted loss
of 10
cents per share for the quarter ended in December. The mean
expectation of two analysts for the quarter was for a loss of 6
cents per share.
* Revenue fell 7.5% to $2.56 million from a year ago;
analysts
expected $2.80 million.
* Nephros Inc's reported EPS for the quarter was a loss
of 10
cents.
* The mean earnings estimate of analysts had fallen by
about 2.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Nephros Inc shares had risen by 4.6% this quarter.
* The company reported a quarterly loss of $918 thousand.
* Wall Street's median 12-month price target for Nephros Inc
is
$3.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
March 8 at 10:46 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.06 -0.10 Missed
Sep. 30 2022 -0.11 -0.31 Missed
Jun. 30 2022 -0.15 -0.12 Beat
Mar. 31 2022 -0.11 -0.20 Missed